{
  "lang": "en",
  "h1" : "Safety/efficiency" ,
  "p" : "   The safety and efficacy of the vaccines adopted in Morocco for the vaccination campaign against the COVID-19 virus\n        have been confirmed through positive findings and clinical trials conducted in Morocco and in other countries.\n        To this end, a high-level scientific committee is monitoring this process. \n According to the ministry, the phase III clinical trial of the Sinopharm vaccine showed an overall efficacy of 86% and good safety.\n\nIn addition, the phase III clinical trial of the Sinopharm Wuhan vaccine, part of which took place in Morocco, included people aged 60 and over. \"The preliminary results showed good tolerance in this population\", it assured."



}